My Next Health to Support NFL funded University of Regina Research on Concussions and Pain Management

1.5 min readPublished On: February 4th, 2022By

NEW YORK – My Next Health Inc. announced its $400,000 USD in-kind support of the medical research team at the University of Regina in Canada, along with the $570,030 USD awarded from the National Football League (NFL) to investigate the use of cannabinoids – the naturally occurring compounds found in the cannabis plant – in the treatment of concussions and for pain management in football players. The medical team from Regina was one of two selected along with the University of California San Diego from 106 proposals initiated by the NFL and the NFL Players Association’s Joint Pain Management Committee in June of 2021.

The research will be led by Dr. Patrick Neary, an exercise physiologist and professor at the University of Regina’s Faculty of Kinesiology and Health Studies. Dr. Neary has been working in the area of concussion prevention and treatment for more than 15 years. “We are grateful for the cannabinoid formulations which are being provided by My Next Health for this study as well as their groundbreaking functional genomics-based insights into chronic pain. We believe My Next Health’s platform will revolutionize the way clinical trials will be conducted in the future and we look forward to working with their world class team to make this research a resounding success.”, said Dr. Neary.

Dr. Richard Heinzl, a Harvard and Oxford University educated global health specialist, is the Chief Executive Officer of My Next Health. He states, “We are very excited to work under Dr. Neary’s exceptional leadership and interdisciplinary team to improve the lives of all of those who suffer from the effects related to concussions including chronic pain. We commend the National Football League for providing funding to this most important research endeavor.”

(This information is primarily sourced from My Next Health Inc.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!